• 5-hme-dCTP: Decoding Plant Epigenetic Dynamics Beyond Mappin

  2026-05-27

  Explore how 5-hme-dCTP (5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate) transforms plant epigenetic research by enabling functional analysis of DNA hydroxymethylation. This article uniquely connects single-base mapping innovations to actionable assay design and practical epigenomic discovery.

• tFUS Suppresses Post-Stroke Neuroinflammation via SHP2 Pathw

  2026-05-26

  This study demonstrates that transcranial focused ultrasound stimulation (tFUS) alleviates NLRP3-mediated neuroinflammation following ischemic stroke by modulating the Nespas/miR-383-3p/SHP2 axis in microglia. The findings define a molecular mechanism for tFUS neuroprotection and highlight the SHP2 signaling pathway as a target for intervention in stroke-related neuroinflammation.

• 2X Taq PCR Master Mix: Streamlined PCR for Genotyping & TA C

  2026-05-26

  The 2X Taq PCR Master Mix (with dye) accelerates PCR setup and analysis for genotyping, TA cloning, and pathogen detection, thanks to its ready-to-load dye and robust amplification chemistry. Built for reproducibility and workflow simplicity, it is ideal for demanding molecular biology applications where error reduction and throughput matter.

• Sulfo-NHS-LC-Biotin: Practical Guide for Protein Biotinylati

  2026-05-26

  Sulfo-NHS-LC-Biotin provides a water-soluble, membrane-impermeable solution for covalent biotin labeling of primary amines, enabling selective cell surface protein biotinylation in fully aqueous conditions. It is not suitable for reversible workflows or for labeling intracellular targets due to its irreversible chemistry and lack of membrane permeability.

• Kanamycin Sulfate: Precision Workflows for Microbiology Anti

  2026-05-25

  Kanamycin Sulfate provides unmatched reliability as a water-soluble antibiotic for microbiology and antibiotic resistance research, enabling reproducible selection and mechanistic studies. This article delivers actionable protocol enhancements, troubleshooting strategies, and advanced applications that translate bench evidence into robust experimental outcomes.

• TGFBR1 Gene Silencing Mitigates Cardiomyopathy in HFpEF Mice

  2026-05-24

  Shen et al. reveal that silencing the TGFBR1 gene in a mouse model of heart failure with preserved ejection fraction (HFpEF) significantly attenuates cardiac fibrosis, hypertrophy, and adverse remodeling. These mechanistic insights identify TGFBR1 as a promising therapeutic target for HFpEF, supporting further translational research.

• Stiripentol: LDH Inhibition Driving Metabolic-Epigenetic Ins

  2026-05-23

  Explore how Stiripentol, a novel LDH inhibitor, enables translational researchers to dissect the interplay between lactate metabolism, epigenetic modification, and neuroimmunometabolic disease. This article bridges mechanistic advances in lactate signaling with practical strategies for leveraging Stiripentol in advanced epilepsy and tumor microenvironment studies, while mapping a vision for next-generation metabolic therapies.

• CCK-8s Stimulates ANP Secretion via NOX4–PGC-1α–PPAR Signali

  2026-05-22

  This study uncovers how sulfated cholecystokinin octapeptide (CCK-8s) promotes atrial natriuretic peptide (ANP) secretion in isolated beating rat atria. By delineating the NOX4–PGC-1α–PPARα/γ pathway, the research advances understanding of cardiac hormone regulation and redox signaling, with implications for cardiovascular and inflammation studies.

• Tigecycline in Multidrug-Resistant Models: Applied Workflows

  2026-05-22

  Tigecycline, a pioneering glycylcycline antibiotic, enables robust modeling and intervention in multidrug-resistant infection research, including CREC and MRSA. This article delivers actionable workflows, protocol refinements, and troubleshooting tips—empowering researchers to maximize experimental reliability and translational relevance.

• Super-Enhancer-Driven KLF6 Regulates Adipogenesis in hADSCs

  2026-05-21

  Nguyen et al. (2026) reveal that super-enhancer (SE)-mediated induction of KLF6 is pivotal for adipogenic differentiation in human adipose-derived stem cells (hADSCs). Their mechanistic study uncovers how SE activation, eRNA, and transcription factor recruitment orchestrate KLF6 expression and adipogenic gene regulation, offering new directions for studying transcriptional regulation in cell fate decisions.

• TPCA-1: Molecular Precision in NF-κB and Cell Death Pathway

  2026-05-21

  Explore the profound selectivity and mechanistic depth of TPCA-1, a leading IKK-2 inhibitor, and its unique advantages for dissecting NF-κB signaling and cell death pathways. This article offers advanced analysis and actionable guidance for inflammation and rheumatoid arthritis research.

• Phebestin as a Nanomolar Aminopeptidase Inhibitor in Malaria

  2026-05-20

  The referenced study identifies phebestin, a bestatin-related aminopeptidase inhibitor, as a potent antiplasmodial agent with nanomolar efficacy against both chloroquine-sensitive and -resistant Plasmodium falciparum strains. These findings reveal new opportunities for targeting peptidase-mediated processes in malaria parasites, with implications for next-generation antimalarial drug development.

• TCF25 Regulates Lysosomal Acidification in Glucose Starvatio

  2026-05-20

  Ren et al. (2025) identify TCF25 as a critical nutrient sensor that orchestrates metabolic adaptation and cell death under glucose starvation by enhancing lysosomal acidification via V-ATPase. This insight provides a mechanistic link between transcriptional regulation, lysosomal function, and cell fate during metabolic stress, offering new perspectives for targeting metabolic and ischemic disorders.

• Vemurafenib (PLX4032): Advanced Workflows for Melanoma Resea

  2026-05-19

  Vemurafenib (PLX4032) empowers researchers to dissect melanoma cell signaling and resistance with precision, thanks to its potent and selective inhibition of BRAF V600E. This article synthesizes recent multi-omics insights and practical workflow upgrades, providing actionable guidance for robust proliferation and resistance studies.

• 3-Bromopyruvate Induces Ferroptosis to Reverse Cetuximab Res

  2026-05-19

  This study demonstrates that co-treatment with 3-bromopyruvate and cetuximab synergistically overcomes cetuximab resistance in colorectal cancer cells. By inducing autophagy-dependent ferroptosis and apoptosis via the FOXO3a pathway, the findings illuminate therapeutic strategies for drug-resistant metastatic colorectal cancer.

455 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page